Skip to content
Disclosery

EXANE DERIVATIVES: NIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NIO, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4,724 NIO shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4,724 shares
    Change vs previous 13F -5,957 shares

    0.06% of the 13F portfolio, value $102,586.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 10,681 shares
    Change vs previous 13F +4,389 shares

    0.06% of the 13F portfolio, value $224,817.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 6,292 shares
    Change vs previous 13F -3,332 shares

    0.05% of the 13F portfolio, value $199,322.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 9,624 shares
    Change vs previous 13F -2,471 shares

    0.09% of the 13F portfolio, value $342,873.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 12,095 shares
    Change vs previous 13F -143 shares

    0.13% of the 13F portfolio, value $543,779.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 12,238 shares
    Change vs previous 13F -6,248 shares

    0.14% of the 13F portfolio, value $477,016.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 18,486 shares
    Change vs previous 13F +10,126 shares

    0.27% of the 13F portfolio, value $900,966.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 8,360 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $177,373.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).